Generali Investments Management Co LLC Purchases New Shares in Waters Corporation $WAT

Generali Investments Management Co LLC bought a new position in shares of Waters Corporation (NYSE:WAT) in the second quarter, Holdings Channel reports. The fund bought 356 shares of the medical instruments supplier’s stock, valued at approximately $124,000.

Other institutional investors and hedge funds have also modified their holdings of the company. Cetera Investment Advisers increased its position in Waters by 5.3% during the second quarter. Cetera Investment Advisers now owns 4,568 shares of the medical instruments supplier’s stock worth $1,594,000 after acquiring an additional 229 shares during the period. Creative Planning grew its position in shares of Waters by 8.8% during the 2nd quarter. Creative Planning now owns 10,069 shares of the medical instruments supplier’s stock worth $3,514,000 after purchasing an additional 813 shares in the last quarter. SG Americas Securities LLC grew its position in shares of Waters by 226.2% during the 2nd quarter. SG Americas Securities LLC now owns 91,915 shares of the medical instruments supplier’s stock worth $32,082,000 after purchasing an additional 63,739 shares in the last quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS increased its holdings in shares of Waters by 7.5% during the second quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 14,595 shares of the medical instruments supplier’s stock worth $5,094,000 after purchasing an additional 1,016 shares during the period. Finally, Allianz SE acquired a new stake in shares of Waters in the second quarter valued at approximately $277,000. 94.01% of the stock is currently owned by institutional investors and hedge funds.

Waters Stock Performance

NYSE:WAT opened at $379.85 on Monday. Waters Corporation has a twelve month low of $275.05 and a twelve month high of $423.56. The company has a quick ratio of 1.22, a current ratio of 1.75 and a debt-to-equity ratio of 0.55. The stock’s 50-day simple moving average is $331.86 and its 200 day simple moving average is $327.45. The firm has a market capitalization of $22.61 billion, a PE ratio of 34.25, a price-to-earnings-growth ratio of 3.19 and a beta of 1.11.

Waters (NYSE:WAT) last posted its earnings results on Thursday, May 19th. The medical instruments supplier reported $2.29 EPS for the quarter. Waters had a net margin of 21.71% and a return on equity of 38.60%. The firm had revenue of $608.55 million during the quarter. On average, analysts anticipate that Waters Corporation will post 12.86 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of equities analysts have commented on WAT shares. Wells Fargo & Company raised their price objective on Waters from $315.00 to $385.00 and gave the stock an “equal weight” rating in a research note on Wednesday, November 5th. JPMorgan Chase & Co. increased their target price on Waters from $300.00 to $325.00 and gave the stock a “neutral” rating in a report on Thursday, October 9th. Cowen reaffirmed a “hold” rating on shares of Waters in a research note on Wednesday, November 5th. Jefferies Financial Group set a $385.00 price objective on shares of Waters and gave the stock a “buy” rating in a research note on Monday, August 4th. Finally, Rothschild Redb raised shares of Waters to a “strong-buy” rating in a report on Wednesday, October 8th. Two analysts have rated the stock with a Strong Buy rating, six have issued a Buy rating and nine have given a Hold rating to the company. According to data from MarketBeat.com, Waters currently has a consensus rating of “Moderate Buy” and an average price target of $381.57.

Waters Company Profile

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.